Zyprexa linked to Diabetes, Hyperglycemia

Zyprexa: Eli Lilly could be Tagged with $1 Billion Dollar Fine

A four-year investigation into the marketing practices of Zyprexa may result in manufacturer Eli Lilly paying $1 billion in fines to federal and state governments. [MORE: ELI LILLY BILLION DOLLAR FINE]

---

Zyprexa: Suicide can be a Side Effect of Drugs

The news is getting harder and harder to ignore. More drugs are being linked to an increased risk of violence and suicide. While some people would argue that, at least in the case of Zyprexa, it is the underlying condition of the patient that increases the risk of suicide, there are more drugs being linked to this risk, making it more difficult to deny that medications can cause people to commit suicidal acts. [MORE: ZYPREXA SUICIDE]

---

Zyprexa Side Effects are Deadly

There appears to be no group that is safe from the deadly side effects of Zyprexa. Seniors with dementia who are given the drug are at an increased risk of death, adults and children have a risk of suicidal tendencies and those who survive that may suffer from serious weight gain and diabetes. With all these potentially dangerous side effects associated with Zyprexa, can it still be said that the benefits of the drug outweigh the risks? [MORE: ZYPREXA DEADLY]

---

Damning FDA Letter Bolsters case against Zyprexa Maker

A letter sent by the Food and Drug Administration to Eli Lilly in March, 2007 is providing support for claimants suing the company over the under-disclosed side-effects of its antipsychotic drug, Zyprexa, and may even expand the category of potential plaintiffs to include those who took the drug after March 2004, the month the company issued a warning to doctors. [MORE: ZYPREXA FDA LETTER]

---

Zyprexa: Can you trust Eli Lilly?

Eli Lilly has been sued by individuals and sued by way of class action for failure to warn adequately that the drug can cause weight gain, diabetes, hypoglycemia and death. Eli Lilly has also been accused of pushing doctors to prescribe Zyprexa for off-label purposesóunrelated to the FDA approved use of the drugófor example for dementia in seniors. [MORE: ZYPREXA TRUST]

---

Zyprexa: Rampant Off-Label Use

Yet another example of an anti-psychotic drug allegedly presenting links to diabetes and weight gain is Zyprexa, manufactured by Eli Lilly & Co. and prescribed for the treatment of schizophrenia and bipolar mania. [MORE: ZYPREXA OFF-LABEL]

---

Lilly Receives Zyprexa Greetings From Capitol Hill

The Chairman and CEO of Eli Lilly, Sidney Taurel, has become a regular pen pal with lawmakers on Capitol Hill since the company's ten-year campaign to increase profits by promoting the off-label use of Zyprexa for patients covered by public health care programs became the focus of investigations in both houses of Congress. [MORE: GREETINGS FROM CAPITOL HILL]

---

Zyprexa, Risperdal and Seroquel Makers Under Fire

Eli Lilly, Johnson & Johnson, and AstraZeneca, are all named defendants in a new lawsuit filed by the state of Pennsylvania on February 26, 2007, to recover money paid through public health care programs to purchase Zyprexa, Risperdal, and Seroquel, and the costs of medical care for the people injured by these drugs. [MORE: ELI LILLY & OTHERS NAMED DEFENDANTS]

---

Kids Dying From Off-Label Use Of Antipsychotics

A recent USA Today sponsored review of the FDA database from 2000 to 2004 found at least 45 deaths in children under 18 with atypical antipsychotics listed as the "primary suspect," and 1,328 reports of other serious side effects, some life-threatening. [MORE: 45 CHILD DEATHS]

---

Zyprexa Takes Major Hit In Alaska

One of the drugs that the Institute tried to force on the plaintiff was Zyprexa and from here on in, the state cannot force people to take Zyprexa, or any other psychiatric drug, without first proving it to be in the patient's best interests and that there are no less restrictive alternatives available. The ruling is specific to psychiatric drugs. [MORE: ZYPREXA IN ALASKA]

---

Zyprexa: Another Link to Diabetes

In September 2005, Mary Allen was hospitalized and treated for manic depression. She was given Zyprexa. "I was never told about any side effects," she says. "My doctor nor I knew at the time of any correlation between Zyprexa and diabetes. [MORE: ANOTHER LINK TO DIABETES]

---

Public has Right to know Secrets revealed in Zyprexa Documents

In deciding whether to allow Eli Lilly to continue to use court orders to hide documents that show the company illegally marketed Zyprexa for unapproved uses and failed to warn the public about the serious health risks associated with the drug for a decade, the court needs to consider the harm done to the public by Lilly's conduct. [MORE: PUBLIC RIGHTS & ZYPREXA]

---

Criminal Prosecution of Lilly Sought Over Zyprexa

Attorney, Ted Chabasinski, is calling for the criminal prosecution of Eli Lilly executives for hiding the adverse effects of Zyprexa, based in part on articles last month in the New York Times which quote internal company documents that revealed that Lilly knew about the adverse effects for a decade but kept the information hidden. [MORE: ZYPREXA CRIMINAL PROSECUTION]

---

Drug Companies Still Peddling Risperdal and Zyprexa For Off-Label Use

According to Kelly O'Meara, author of the newly released book, Psyched Out, America has a drug problem. "It's not as covert as those illicit and illegal "Just Say No" drugs," she says, "but, rather, Americans have become drug users by way of being diagnosed as suffering from one or a number of alleged mental disorders." [MORE: OFF-LABEL PEDDLING]

---

Drug Marketing Scheme Hits Nation's School System

TeenScreen, the elaborate drug marketing scheme concocted by the pharmaceutical industry and a front group operating out of Columbia University, is being promoted by the Bush administration's recommendation to screen the nation's school population for mental illness. [MORE: TEENSCREEN HITS SCHOOLS]

Zyprexa (Olanzapine), prescribed for the treatment of schizophrenia and bipolar mania, has been linked to diabetes mellitus, hyperglycemia, pancreatitis and blood sugar disorders. There have been 288 reported diabetes cases in Zyprexa patients, with 23 of them being fatal.

Eli Lilly & Co. is accused of heavily promoting Zyprexa as a safe and effective drug for psychotic disorders, while virtually concealing the risks of side effects from doctors and from the patients themselves. In a recent lawsuit, the courts agreed with lawyers representing consumers and found that prior to 2003, Eli Lilly did not properly disclose risks and known side effects of Zyprexa.